Skip to content

Author

F. Sharifianjazi

We have 4 of 133 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Engineering chitosan functionalized extracellular vesicles for targeted brain gene delivery and neurotherapeutics

Gene therapy represents a crucial frontier in modern medicine for brain diseases; however, a significant obstacle hinders its progress. The immense difficulty of therapeutic molecules that deliver to the brain should be in a safe and effective way. The challenge is that blood brain barrier (BBB) blocks most drugs from...

H. Hashemi, Babak Mikaeeli Kangarshahi, Ghasem Takdehghan et al. · 0 citations
Review Sep 2026

Niosomes as Multifunctional Nanocarriers: From Regulated Drug Release to Stimuli-Responsive and Hybrid Therapeutic Systems

The present study emphasises niosomes as versatile nanocarriers with great potential for the next generation of drug delivery and describes the major challenges that need to be overcome for further clinical and commercial translation.

Khashayar Khodaverdi, S. M. Naghib, Ghasem Takdehghan et al. · 0 citations
Jul 2026

Novel electrospun organic–inorganic hybrid scaffold from PCL, gelatin, and bioglass 58 S -cerium oxide nanoparticles for skin tissue engineering

This research provides evidence for the potential use of cerium oxide-doped 58 S bioactive glass nanoparticles in wound dressings, highlighting their non-cytotoxicity, blood compatibility, suitable mechanical properties for skin tissue engineering, antibacterial activity, and therapeutic benefits.

Ahmad Vaez, Sepehr Zamani, Saeed Haghi Daredeh et al. · 0 citations
Review Open access Aug 2026

Multifunctional chitosan/carbon nanotube nanocomposites for programable drug and gene delivery in cancer therapy, wound healing and antimicrobial applications

A new Triple-Stimuli Release Model is presented that provides a computational experimental bridge to expedite preclinical validation while mathematically forecasting concurrent release kinetics and how well molecular dynamics simulations and artificial intelligence combine to forecast toxicity, drug-carrier interaction...

H. Hashemi, Aref Zahiri Ghareh Mosa, Ketevan Tavamaishvili et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.